I sold all my Tesla shares (TSLA), here’s why

  • September 5, 2024
  • 0 Comments

I fully divested from Tesla (TSLA), selling all my shares. I’m going to try to explain why. At Electrek, we like to be clear about our biases rather than claim we have none. I’ve followed Tesla since 2008 and invested in the company after it went public in 2010. I started writing about EVs, and […]

Health Technologies

Researchers develop sensory pen which can read braille

  • September 5, 2024
  • 0 Comments

A pen which can transform braille into English text has been developed which researchers say could improve literacy amongst the visually impaired. Braille literacy is frequently reported as being in decline, this is despite visually impaired people often expressing a desire to learn it, and braille literacy being a highly valued skill by those who […]

Tesla reveals AI product/self-driving roadmap, and it raises questions

  • September 5, 2024
  • 0 Comments

Tesla has revealed its AI product/self-driving roadmap for the next few months, but it raises more questions than it answers. Tesla official AI Roadmap with self-driving software releases September 2024 v12.5.2 with ~3x improved miles between necessary interventions v12.5.2 on AI3 computer (unified models for AI3 and AI4) Actually Smart Summon Cybertruck Autopark Eye-tracking with […]

Wheel-E Podcast: New e-bike from Radio Flyers, Talaria MX5 Sting Pro, more

  • September 5, 2024
  • 0 Comments

This week on Electrek’s Wheel-E podcast, we discuss the most popular news stories from the world of electric bikes and other nontraditional electric vehicles. This time that includes new e-bike launches from Radio Flyer and Fucare, Denver’s popular e-bike subsidies, Australia Post using new electric motorbikes for mail delivery, Talaria Sting Pro MX5 launch, and more. The […]

Digital therapeutics data show the category can be held to high clinical standards

  • September 5, 2024
  • 0 Comments

The announcement from Click Therapeutics that its digital therapeutic CT-132 met its primary endpoint in the ReMMi-D pivotal trial is a key development for migraine treatment and the digital health community. The study’s results point to the potential of digital therapeutics as a complement to existing medications and as a scientifically validated option capable of improving patient outcomes in […]

U.S. crude oil near $69 per barrel as OPEC+ delays production boost

  • September 5, 2024
  • 0 Comments

U.S. crude oil pulled back slightly Thursday to close near $69 per barrel, as OPEC+ delays plans to boost production after futures sold off steeply this week. OPEC+ members have delayed a production hike of 180,000 barrels per day by two months, two sources told CNBC. The production increase was originally scheduled for October. “There’s […]